“`html
Genpact Ltd (NYSE: G) shares have surpassed the average analyst 12-month target price of $45.73, trading at $45.82 as of recent market activity. Analysts will likely respond by either downgrading their valuations or adjusting their target prices based on the stock’s performance and the company’s fundamentals.
Currently, there are 11 different analyst targets for Genpact, with a lowest target of $35.00 and a highest of $55.00, yielding a standard deviation of $5.551. The average rating remains stable at 2.58, indicating a general consensus of “Hold,” with 2 strong buy ratings, 1 buy, and 9 holds.
“`
